Health Developments: From Therapy Trials to Global Flu Outbreaks
Key health updates include Regeneron's promising immune disorder therapy trial, recovery of the first U.S. screwworm patient amidst rancher concerns, efforts to create an oral weight-loss pill by top pharma, bird flu outbreaks in Bulgaria and Argentina affecting poultry importation, and USDJ's probe into UnitedHealth's prescription practices.
Two major developments in health made headlines this week, with Regeneron's experimental therapy showing significant progress in treating generalized myasthenia gravis, an immune disorder that impairs daily functions. The therapy successfully met its main goals in a late-stage trial, offering hope for enhanced patient quality of life.
In contrast, the outbreak of bird flu in Bulgaria and subsequent detection in Argentina has sparked precautionary measures. Bulgaria reported cases on three farms resulting in mass culling, while Chile suspended poultry imports from Argentina after a confirmed case of avian influenza.
Meanwhile, the U.S. Justice Department has expanded its investigation into pharmacy benefit management practices at UnitedHealth Group's Optum Rx, reflecting growing scrutiny over prescription management and reimbursement techniques.
(With inputs from agencies.)
ALSO READ
Screwworm Alert: USDA Responds to Human Case in U.S.
Screwworm Alert: How a Silent Parasite Poses a Billion-Dollar Threat
Health Challenges: Screwworm in the U.S. and Bird Flu in Argentina
Health Sensations: From Screwworm Recovery to India's Protein Craze
First U.S. Case of Human Screwworm Linked to Central American Outbreak
Google News